Raviteja Bulusu

775 total citations · 1 hit paper
9 papers, 561 citations indexed

About

Raviteja Bulusu is a scholar working on Molecular Biology, Oncology and Pharmaceutical Science. According to data from OpenAlex, Raviteja Bulusu has authored 9 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pharmaceutical Science. Recurrent topics in Raviteja Bulusu's work include Pancreatic and Hepatic Oncology Research (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Drug Solubulity and Delivery Systems (2 papers). Raviteja Bulusu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Drug Solubulity and Delivery Systems (2 papers). Raviteja Bulusu collaborates with scholars based in United States, India and Cameroon. Raviteja Bulusu's co-authors include Nagavendra Kommineni, Wahid Khan, Mandip Singh, Vaskuri G. S. Sainaga Jyothi, Pradeep Kumar Bolla, Mohammed Berrada, Fouad Damiri, Md. Habibur Rahman, Mousa O. Germoush and Hamdan S. Al-malky and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and Materials.

In The Last Decade

Raviteja Bulusu

8 papers receiving 547 citations

Hit Papers

Amorphous solid dispersio... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products
    2020 280 citations Raviteja Bulusu, Nagavendra Kommineni et al. International Journal of Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raviteja Bulusu United States 6 293 126 102 99 97 9 561
André O’Reilly Beringhs United States 15 184 0.6× 96 0.8× 121 1.2× 133 1.3× 103 1.1× 33 590
Sunny Shah India 16 322 1.1× 156 1.2× 99 1.0× 103 1.0× 112 1.2× 50 678
María Cristina Martínez-Ohárriz Spain 17 335 1.1× 173 1.4× 118 1.2× 67 0.7× 119 1.2× 36 670
Alberto Rubin Pedrazzo Italy 13 189 0.6× 90 0.7× 142 1.4× 146 1.5× 212 2.2× 22 645
Bhingaradiya Nutan India 9 205 0.7× 104 0.8× 97 1.0× 135 1.4× 167 1.7× 15 664
Arantza Zornoza Spain 14 215 0.7× 87 0.7× 73 0.7× 55 0.6× 60 0.6× 34 520
Kifayat Ullah Khan Pakistan 14 344 1.2× 45 0.4× 76 0.7× 79 0.8× 178 1.8× 35 633
Alpana A. Thorat United States 9 179 0.6× 216 1.7× 128 1.3× 114 1.2× 96 1.0× 14 691
G. Agusti France 13 163 0.6× 143 1.1× 124 1.2× 171 1.7× 212 2.2× 41 739
Avinash Kumar India 5 163 0.6× 92 0.7× 68 0.7× 73 0.7× 75 0.8× 10 437

Countries citing papers authored by Raviteja Bulusu

Since Specialization
Citations

This map shows the geographic impact of Raviteja Bulusu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raviteja Bulusu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raviteja Bulusu more than expected).

Fields of papers citing papers by Raviteja Bulusu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raviteja Bulusu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raviteja Bulusu. The network helps show where Raviteja Bulusu may publish in the future.

Co-authorship network of co-authors of Raviteja Bulusu

This figure shows the co-authorship network connecting the top 25 collaborators of Raviteja Bulusu. A scholar is included among the top collaborators of Raviteja Bulusu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raviteja Bulusu. Raviteja Bulusu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kumar, Raj, Nagavendra Kommineni, Keshaw Ram Aadil, et al.. (2025). Lipid Nanoparticle-based mRNA Therapeutics for Infectious Diseases. International Journal of Pharmaceutics. 687. 126420–126420.
2.
Bulusu, Raviteja, et al.. (2024). Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer. European Journal of Pharmaceutical Sciences. 196. 106754–106754. 4 indexed citations
3.
Bulusu, Raviteja, et al.. (2023). Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. BMC Cancer. 23(1). 435–435. 7 indexed citations
4.
Bulusu, Raviteja, et al.. (2023). Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. International Journal of Molecular Sciences. 24(5). 4288–4288. 6 indexed citations
5.
Jyothi, Vaskuri G. S. Sainaga, et al.. (2022). Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update. International Journal of Pharmaceutics. 624. 122022–122022. 106 indexed citations
6.
Bulusu, Raviteja, et al.. (2022). Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer. BMC Cancer. 22(1). 1345–1345. 2 indexed citations
7.
Damiri, Fouad, Nagavendra Kommineni, Samuel Ogbeide Ebhodaghe, et al.. (2022). Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges. Pharmaceuticals. 15(2). 190–190. 97 indexed citations
8.
Damiri, Fouad, Swetha Andra, Nagavendra Kommineni, et al.. (2022). Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review. Materials. 15(15). 5392–5392. 59 indexed citations
9.
Bulusu, Raviteja, et al.. (2020). Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. International Journal of Pharmaceutics. 586. 119560–119560. 280 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André O’Reilly Beringhs Breakdown of academic impact, for papers by Sunny Shah Breakdown of academic impact, for papers by María Cristina Martínez-Ohárriz Breakdown of academic impact, for papers by Alberto Rubin Pedrazzo Breakdown of academic impact, for papers by Bhingaradiya Nutan Breakdown of academic impact, for papers by Arantza Zornoza Breakdown of academic impact, for papers by Kifayat Ullah Khan Breakdown of academic impact, for papers by Alpana A. Thorat Breakdown of academic impact, for papers by G. Agusti Breakdown of academic impact, for papers by Avinash Kumar
Rankless by CCL
2026